4.6 Review

Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy

Related references

Note: Only part of the references are listed.
Article Toxicology

Toxicity of anticancer drugs in human placental tissue explants and trophoblast cell lines

Gaby A. M. Eliesen et al.

Summary: The study aimed to compare the effects of various anticancer drugs on viability and steroidogenesis in placental tissue explants and trophoblast cell lines. Most anticancer drugs affected viability significantly in both placental explants and trophoblast cell lines, highlighting the placenta as a potential target organ for toxicity of these drugs. The results suggest the importance of studying placental toxicity of anticancer drugs during pregnancy.

ARCHIVES OF TOXICOLOGY (2021)

Review Oncology

Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?

Antonio Ruggiero et al.

Summary: The study emphasized the importance of understanding the renal toxic effects of cisplatin in children and the controversial use of diuretics for nephroprotection, given the lack of guidelines and inconclusive data on their utility.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)

Review Oncology

Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents

Laure Benoit et al.

Summary: This study reviewed data on the use of anti-cancer treatments in pregnant women and the transplacental transfer of drugs, aiming to guide clinicians in choosing the best treatment options and providing balanced information to pregnant patients. The occurrence of cancer during pregnancy is increasing, requiring careful consideration of the benefit-risk ratio for both mother and fetus during treatment.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment

Silvia Triarico et al.

Summary: Vincristine-induced peripheral neurotoxicity (VIPN) is a common side effect in pediatric cancer patients undergoing vincristine chemotherapy, leading to potential complications such as treatment delays or discontinuation. The pathogenesis of VIPN involves complex mechanisms including damage to nerve cell endothelium, mitochondria, and microtubules, with both patient-related and treatment-related factors contributing to its development. Despite research into various drugs for prophylaxis and treatment, consensus on the best approach for VIPN management in pediatric oncology patients remains elusive.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Obstetrics & Gynecology

Fetal exposure to capecitabine and temozolomide during the first trimester: A case report

Maria Castellanos et al.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2020)

Review Oncology

Update on the Management of Breast Cancer during Pregnancy

Francesca Poggio et al.

CANCERS (2020)

Review Hematology

Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations

Elisabetta Abruzzese et al.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)

Review Oncology

Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis

Flora Zagouri et al.

CANCER TREATMENT REVIEWS (2019)

Article Oncology

Effects of in-utero exposure to chemotherapy on fetal brain growth

Sofia Passera et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)

Article Oncology

Pharmacokinetics of dacarbazine (DTIC) in pregnancy

Ira Kantrowitz-Gordon et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)

Article Hematology

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

Agustin Aviles et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2018)

Article Biochemistry & Molecular Biology

Trophoblast: The central unit of fetal growth, protection and programming

Frantisek Staud et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)

Article Oncology

Irinotecan during pregnancy in metastatic colon cancer

Massimo Cirillo et al.

TUMORI (2018)

Article Oncology

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Jorine de Haan et al.

CASE REPORTS IN ONCOLOGY (2018)

Review Clinical Neurology

Rituximab before and during pregnancy A systematic review, and a case series in MS and NMOSD

Gitanjali Das et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)

Article Surgery

Synchronous colorectal liver metastases in pregnancy and post-partum

Danielle E. Robson et al.

ANZ JOURNAL OF SURGERY (2017)

Review Gastroenterology & Hepatology

Colorectal cancer diagnosed during pregnancy: systematic review and treatment pathways

Gianluca Pellino et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Oncology

Frequency of Pregnancy Related Cancer A Population Based Linkage Study in Lombardy, Italy

Fabio Parazzini et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)

Article Reproductive Biology

Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy

Stephanie Padberg et al.

REPRODUCTIVE TOXICOLOGY (2017)

Review Oncology

Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide

Padmanabhan Rengasamy

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)

Article Biotechnology & Applied Microbiology

Prenatal effects of transplacental exposure to ifosfamide in rats

M. A. M. Helal

BIOTECHNIC & HISTOCHEMISTRY (2016)

Article Pharmacology & Pharmacy

Exercise during pregnancy decreases doxorubicin-induced cardiotoxic effects on neonatal hearts

Veronica B. Brito et al.

TOXICOLOGY (2016)

Review Obstetrics & Gynecology

Why is placentation abnormal in preeclampsia?

Susan J. Fisher

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)

Review Oncology

Targeted agents for cancer treatment during pregnancy

Matteo Lambertini et al.

CANCER TREATMENT REVIEWS (2015)

Editorial Material Biochemistry & Molecular Biology

Pharmacokinetic considerations in the use of anticancer drugs during pregnancy: challenges and new developments

David J. Bell et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)

Review Ophthalmology

Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature

Silvio Polizzi et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)

Review Biology

The role of invasive trophoblast in implantation and placentation of primates

Anthony M. Carter et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)

Article Toxicology

Human placental cell and tissue uptake of doxorubicin and its liposomal formulations

Suvi K. Soininen et al.

TOXICOLOGY LETTERS (2015)

Review Oncology

Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting

Frederic Amant et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)

Article Obstetrics & Gynecology

Effect of anti-vascular endothelial growth factor antibody during early fetal development in rats

Ikbal Kaygusuz et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2014)

Article Obstetrics & Gynecology

A Child With Severe Hearing Loss Associated With Maternal Cisplatin Treatment During Pregnancy

Eric C. T. Geijteman et al.

OBSTETRICS AND GYNECOLOGY (2014)

Article Reproductive Biology

Methotrexate embryopathy after exposure to low weekly doses in early pregnancy

Maria Cecilia Martin et al.

REPRODUCTIVE TOXICOLOGY (2014)

Review Oncology

Platinum compounds in children with cancer: toxicity and clinical management

Antonio Ruggiero et al.

ANTI-CANCER DRUGS (2013)

Article Oncology

Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy

Aglaia Maleka et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Obstetrics & Gynecology

Incidence of Pregnancy-Associated Cancer in Denmark, 1977-2006

Simone Eibye et al.

OBSTETRICS AND GYNECOLOGY (2013)

Article Obstetrics & Gynecology

Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy

El-Said Abdel-Hady et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)

Review Developmental Biology

The all-or-none phenomenon revisited

Margaret P. Adam

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2012)

Review Obstetrics & Gynecology

Transient ventricular hypocinesia after in utero anthracyclines exposure: a case-report and review of the literature

Emilia Parodi et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)

Review Biochemistry & Molecular Biology

Mechanisms of implantation: strategies for successful pregnancy

Jeeyeon Cha et al.

NATURE MEDICINE (2012)

Editorial Material Oncology

Taxanes during Pregnancy: Probably Safe, but Still to Be Optimized

Paul Berveiller et al.

ONCOLOGY (2012)

Article Hematology

Pregnancy outcomes after maternal exposure to rituximab

Eliza F. Chakravarty et al.

BLOOD (2011)

Article Obstetrics & Gynecology

Chemotherapy in Pregnancy

Molly Brewer et al.

CLINICAL OBSTETRICS AND GYNECOLOGY (2011)

Article Obstetrics & Gynecology

Addressing concerns about cisplatin application during pregnancy

Malgorzata Lanowska et al.

JOURNAL OF PERINATAL MEDICINE (2011)

Article Obstetrics & Gynecology

Substantial Variation in Transplacental Transfer of Chemotherapeutic Agents in a Mouse Model

Kristel Van Calsteren et al.

REPRODUCTIVE SCIENCES (2011)

Letter Ophthalmology

Early loss of pregnancy after intravitreal bevacizumab injection

Petros Petrou et al.

ACTA OPHTHALMOLOGICA (2010)

Letter Oncology

Taxanes for breast cancer during pregnancy: a systematic review

O. Mir et al.

ANNALS OF ONCOLOGY (2010)

Review Medicine, Research & Experimental

The placenta: transcriptional, epigenetic, and physiological integration during development

Emin Maltepe et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Medicine, General & Internal

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Administration of oxaliplatin to a pregnant woman with rectal cancer

Michael Gensheimer et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)

Article Obstetrics & Gynecology

Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy

M. Gurumurthy et al.

JOURNAL OF PERINATOLOGY (2009)

Letter Oncology

Is imatinib safe during pregnancy?

Tuphan Kanti Dolai et al.

LEUKEMIA RESEARCH (2009)

Article Obstetrics & Gynecology

Irinotecan Use During Pregnancy

Justin Taylor et al.

OBSTETRICS AND GYNECOLOGY (2009)

Article Hematology

The effects of imatinib on pregnancy outcome

Seonaid M. Pye et al.

BLOOD (2008)

Article Oncology

Management of Malignant Gliomas During Pregnancy A Case Series

Deborah T. Blumenthal et al.

CANCER (2008)

Article Obstetrics & Gynecology

Transport kinetics of cisplatin in the perfused human placental lobule invitro

Eyad Al-Saleh et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)

Article Hematology

Rituximab combined with chemotherapy for lymphoma during pregnancy

J. Rey et al.

LEUKEMIA RESEARCH (2008)

Article Oncology

Successful treatment of small cell lung cancer during pregnancy

Paul G. Kluetz et al.

LUNG CANCER (2008)

Article Obstetrics & Gynecology

Trastuzumab use for metastatic breast cancer in pregnancy

Renuka Sekar et al.

OBSTETRICS AND GYNECOLOGY (2007)

Article Developmental Biology

Animal models of human placentation - A review

A. M. Carter

PLACENTA (2007)

Article Obstetrics & Gynecology

Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary

Makoto Motegi et al.

OBSTETRICS AND GYNECOLOGY (2007)

Article Oncology

Delivery of a healthy baby after first-trimester maternal exposure to lapatinib

Hanna Kelly et al.

CLINICAL BREAST CANCER (2006)

Article Hematology

Hematological malignancy and pregnancy:: a single-institution experience of 21 cases

I Dilek et al.

CLINICAL AND LABORATORY HAEMATOLOGY (2006)

Review Oncology

Cancer and pregnancy: Poena magna, not anymore

G Pentheroudakis et al.

EUROPEAN JOURNAL OF CANCER (2006)

Article Pharmacology & Pharmacy

Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy

DM Niedermeier et al.

PHARMACOTHERAPY (2005)

Article Developmental Biology

Developmental abnormalities in rat embryos leading to tibial ray deficiencies induced by busulfan

M Otsuji et al.

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2005)

Review Oncology

Use of chemotherapy during human pregnancy

E Cardonick et al.

LANCET ONCOLOGY (2004)

Article Developmental Biology

What can comparative studies of placental structure tell us? A review

AC Enders et al.

PLACENTA (2004)

Article Oncology

Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients

N Germann et al.

ANNALS OF ONCOLOGY (2004)

Review Pharmacology & Pharmacy

Drug transfer and metabolism by the human placenta

MR Syme et al.

CLINICAL PHARMACOKINETICS (2004)

Article Obstetrics & Gynecology

Idarubicin administered during pregnancy: Its effects on the fetus

K Matsuo et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2004)

Article Oncology

Good outcome for infant of mother treated with chemotherapy for Ewing sarcoma at 25 to 30 weeks' gestation

W Nakajima et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)

Article Oncology

Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant

A Alexander et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Anatomy & Morphology

Effects of prenatal procarbazine administration on intrauterine development in rats

FA Malek et al.

ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2003)

Article Obstetrics & Gynecology

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

C Achtari et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)